In the experience of Jeffrey Sobell, M.D., treatment of moderate-to-severe plaque psoriasis with biologics has been extremely rewarding and has produced some of the happiest and most satisfied patients he sees. Optimizing safety and success, however, requires knowledge of the warnings and precautions pertaining to each agent, careful patient follow-up, and ongoing counseling.

Speaking at the Fall Clinical Dermatology Conference, Dr. Sobell discussed how he tailors his selection of a biologic agent to the individual’s medical history along with his approaches for treatment initiation and follow-up.

Read the full article at